176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
View analysts' price targets and recommendations, and compare them with competitors.
$207.00
Analysts expect the stock price to increase by 16.41%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
60.92B
Revenue has increased from the previous period.
125.85%
Revenue growth rate has increased from the previous period.
35.58B
EBITDA has increased from the previous period.
58.41%
EBITDA margin has increased from the previous period.
34.08B
EBIT has increased from the previous period.
55.93%
EBIT margin has increased from the previous period.
1.51B
Depreciation has decreased from the previous period.
25.98B
Total cash has increased from the previous period.
42.65%
Cash percentage has decreased from the previous period.
10.00B
Receivables have increased from the previous period.
16.41%
Receivables percentage has increased from the previous period.
5.28B
Inventories have increased from the previous period.
8.67%
Inventory percentage has decreased from the previous period.
2.70B
Accounts payable has increased from the previous period.
4.43%
Payables percentage has increased from the previous period.
-1.07B
Capital expenditure has decreased from the previous period.
-1.75%
CapEx percentage has decreased from the previous period.
12.05%
WACC has decreased from the previous period.
12.08%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
1.66
Beta is unchanged from the previous period.
24.94B
Diluted shares outstanding is unchanged from the previous period.
11.06B
Total debt is unchanged from the previous period.
3.35T
Total equity is unchanged from the previous period.
3.36T
Total capital is unchanged from the previous period.
0.33%
Debt weighting is unchanged from the previous period.
99.67%
Equity weighting is unchanged from the previous period.
29.99B
EBIAT has increased from the previous period.
25.64B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
1.62T
Terminal value is unchanged from the previous period.
1.12T
Enterprise value has increased from the previous period.
3.78B
Net debt is unchanged from the previous period.
1.12T
Equity value has increased from the previous period.
44.94
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
9.50B
The estimated revenue has increased from the previous period.
2.25B
The estimated EBITDA has decreased from the previous period.
0.10
The estimated EPS has increased from the previous period.
1.87B
The estimated net income has increased from the previous period.
2.08B
The estimated EBIT has decreased from the previous period.
562.85M
The estimated SG&A expenses have decreased from the previous period.
